Alexander Raeside

Medawar Building for Pathogen Research

Papers

1

Total Citations

31

H-Index

1

About

Dr. Alexander Raeside is a pioneering biotechnologist whose work centers on antibody discovery and membrane protein biology. His most significant contribution is the development of a novel mammalian display system for selecting antibodies against membrane proteins in their native conformations—a longstanding challenge in the field. This breakthrough, detailed in his highly cited 2020 paper (31 citations), addresses the critical difficulty of generating reliable, specific antibodies against targets that are notoriously difficult to express and purify. By enabling the selection of antibodies that recognize membrane proteins as they naturally exist on cell surfaces, Raeside’s method has profound implications for both basic research and therapeutic development. His work bridges a key gap in immunotechnology, offering a robust platform for discovering tools that are more physiologically relevant. This innovation not only advances the study of membrane proteins—which constitute a majority of drug targets—but also promises to accelerate the development of diagnostic and therapeutic antibodies. Raeside’s research stands out for its practical impact, providing a solution to a bottleneck that has long hindered progress in structural biology and pharmacology.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Development of a novel mammalian display system for selection of antibodies against membrane proteins
31 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Medawar Building for Pathogen Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago